Online first
Original article
Published online: 2025-01-16
Therapeutic potential of stromal vascular fraction in early diabetic nephrotoxicity: a histomorphometric and immunohistochemical analysis in type 2 diabetes rat model
1
, 23, 14, 1, 5, 67, 1
, 23, 14, 1, 5, 67, 1
DOI: 10.5603/fm.103545
Pubmed: 39821782
Abstract
Background: Diabetic nephropathy (DN), a common complication of type 2 diabetes (T2D), significantly contributes to end-stage kidney disease (ESKD). Despite conventional treatments aimed at slowing disease progression, there is a pressing need for novel therapies. This study evaluates the potential therapeutic impact of adipose tissue derived stromal vascular fraction (SVF) on early diabetic nephrotoxicity in a rat model. Materials and methods: Thirty-one male albino rats were divided into control and diabetic groups, with the latter further split into untreated (T2Da) and SVF-treated (T2Db) subgroups. Biochemical, histological, immunohistochemical, and morphometric analyses were conducted. Results: We demonstrated that SVF treatment reduced oxidative stress, lowered serum creatinine, and improved renal architecture by mitigating fibrosis and cellular infiltration, suggesting enhanced tissue regeneration and reduced inflammation. SVF also facilitated cellular repair, indicated by increased endothelial cell proliferation and reduced glomerular damage. Conclusions: This study underscores SVF's potential as a promising regenerative approach for managing early-stage DN, warranting further research to elucidate its mechanisms.
Keywords: SVFdiabetesnephropathyglomeruloscleosis
References
- Ahmed A, Salama E, Shehata H, et al. The role of Ischemia modified albumin in detecting diabetic nephropathy. SVU Int J Med Sci. 2023; 6(1): 359–367.
- Al-Qabbaa SM, Qaboli SI, Alshammari TK, et al. Sitagliptin mitigates diabetic nephropathy in a rat model of streptozotocin-induced type 2 diabetes: possible role of PTP1B/JAK-STAT pathway. Int J Mol Sci. 2023; 24(7).
- Asmamaw T, Genet S, Menon M, et al. Early detection of renal impairment among patients with type 2 diabetes mellitus through evaluation of serum cystatin c in comparison with serum creatinine levels: a cross-sectional study. Diabetes Metab Syndr Obes. 2020; 13: 4727–4735.
- Atia T, Iqbal MZ, Fathy Ahmed H, et al. Vitamin d supplementation could enhance the effectiveness of glibenclamide in treating diabetes and preventing diabetic nephropathy: a biochemical, histological and immunohistochemical study. J Evid Based Integr Med. 2022; 27: 2515690X221116403.
- Bancroft JD, Gamble M. Connective tissue stains. In: Bancroft JD, Gamble M. ed. Theory and practice of histological techniques, 6th ed. Elsevier Health Science, Edinburgh 2008.
- Carstens MH, García N, Mandayam S, et al. Safety of stromal vascular fraction cell therapy for chronic kidney disease of unknown cause (mesoamerican nephropathy). Stem Cells Transl Med. 2023; 12(1): 7–16.
- Dalmaijer ES, Nord CL, Astle DE. Statistical power for cluster analysis. BMC Bioinformatics. 2022; 23(1): 205.
- Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD). Diabetes Care. 2022; 45(11): 2753–2786.
- D'Marco L. Congestive nephropathy. Int J Environ Res Public Health. 2022; 19(5): 2499.
- Dong Xi, Lu S, Tian Yu, et al. Bavachinin protects the liver in NAFLD by promoting regeneration via targeting PCNA. J Adv Res. 2024; 55: 131–144.
- Doroudian M, O'Neill A, O'Reilly C, et al. Aerosolized drug-loaded nanoparticles targeting migration inhibitory factors inhibit Pseudomonas aeruginosa-induced inflammation and biofilm formation. Nanomedicine (Lond). 2020; 15(30): 2933–2953.
- El-Kady MM, Naggar RA, Guimei M, et al. Early renoprotective effect of ruxolitinib in a rat model of diabetic nephropathy. Pharmaceuticals (Basel). 2021; 14(7).
- Fareed SA, Yousef EM, Abd El-Moneam SM. Assessment of effects of rosemary essential oil on the kidney pathology of diabetic adult male albino rats. Cureus. 2023; 15(3): e35736.
- Farid MF, Abouelela YS, Yasin NAE, et al. Laser-activated autologous adipose tissue-derived stromal vascular fraction restores spinal cord architecture and function in multiple sclerosis cat model. Stem Cell Res Ther. 2023; 14(1): 6.
- García-Pedraza JÁ, García-Domingo M, Gómez-Roso M, et al. Hypertension exhibits 5-HT receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature. Hypertens Res. 2019; 42(5): 618–627.
- Geng W, Zhang Z, Yang Z, et al. Non-aqueous synthesis of high-quality Prussian blue analogues for Na-ion batteries. Chem Commun (Camb). 2022; 58(28): 4472–4475.
- Goncharov EN, Koval OA, Igorevich EI, et al. Analyzing the clinical potential of stromal vascular fraction: a comprehensive literature review. Medicina (Kaunas). 2024; 60(2).
- Goncharov EN, Koval OA, Nikolaevich Bezuglov E, et al. Comparative analysis of stromal vascular fraction and alternative mechanisms in bone fracture stimulation to bridge the gap between nature and technological advancement: a systematic review. Biomedicines. 2024; 12(2).
- Guo W, Song Y, Sun Y, et al. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: evidence from NHANES 2011-2018. Front Endocrinol (Lausanne). 2022; 13: 1071465.
- Hayashi S, Yagi R, Taniguchi S, et al. A novel method for processing adipose-derived stromal stem cells using a closed cell washing concentration device with a hollow fiber membrane module. Biomed Microdevices. 2021; 23(1): 3.
- Huang Q, Tian H, Tian L, et al. Inhibiting Rev-erbα-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes. Free Radic Biol Med. 2023; 209(Pt 1): 135–150.
- Ighodaro OM, Adeosun AM, Ujomu TS, et al. Combination therapy of Allium cepa L. and Cucumis sativa L. extracts in streptozotocin-induced diabetic rat model. Futur J Pharm Sci. 2021; 7(1): 227–234.
- Karina K, Krisandi G, Rosadi I, et al. Stromal vascular fraction and autologous activated platelet-rich plasma combination in treatment of type 2 diabetes: a single center retrospective study. Clin Diabetol. 2023; 12(4): 247–252.
- Kiernan JA. Histological and histochemical methods: Theory and practice. 5th edition. Arnold, London 2015: 132–212.
- Kim DL, Lee SE, Kim NH. Renal protection of mineralocorticoid receptor antagonist, finerenone, in diabetic kidney disease. Endocrinol Metab (Seoul). 2023; 38(1): 43–55.
- Li M, Tian Y, Cheng R, et al. Clinical efficacy of stromal vascular fraction gel in the treatment of mature striae distensae. Skin Res Technol. 2024; 30(1): e13551.
- Li X, Wang L, Liu M, et al. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study. Front Endocrinol (Lausanne). 2023; 14: 1285509.
- Liao Z, Kong Y, Zeng L, et al. Effects of high-fat diet on thyroid autoimmunity in the female rat. BMC Endocr Disord. 2022; 22(1): 179.
- Luo WM, Su JY, Xu T, et al. Prevalence of diabetic retinopathy and use of common oral hypoglycemic agents increase the risk of diabetic nephropathy — a cross-sectional study in patients with type 2 diabetes. Int J Environ Res Public Health. 2023; 20(5).
- Ma X, Ma J, Leng T, et al. Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention. Ren Fail. 2023; 45(1): 2146512.
- Meligy FY, Abo Elgheed AT, Alghareeb SM. Therapeutic effect of adipose-derived mesenchymal stem cells on Cisplatin induced testicular damage in adult male albino rat. Ultrastruct Pathol. 2019; 43(1): 28–55.
- Najafi A, Pourfarzam M, Zadhoush F. Oxidant/antioxidant status in type-2 diabetes mellitus patients with metabolic syndrome. J Res Med Sci. 2021; 26: 6.
- Oliva-Damaso N, Mora-Gutiérrez JM, Bomback AS. Glomerular diseases in diabetic patients: implications for diagnosis and management. J Clin Med. 2021; 10(9).
- Ossendorff R, Menon A, Schildberg FA, et al. A worldwide analysis of adipose-derived stem cells and stromal vascular fraction in orthopedics: current evidence and applications. J Clin Med. 2023; 12(14).
- Sert NP, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLOS Biol. 2020; 18(7): e3000410.
- Sekiya I, Larson BL, Smith JR, et al. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002; 20(6): 530–541.
- Shi Q, Wang J, Cheng Y, et al. Palbinone alleviates diabetic retinopathy in STZ-induced rats by inhibiting NLRP3 inflammatory activity. J Biochem Mol Toxicol. 2020; 34(7): e22489.
- Suvarna SK, Layton C, Bancroft JD. Immunohistochemical and immunofluorescent techniques. In: Suvarna SK, Layton C, Bancroft JD. ed. Bancroft’s Theory and practice of histological techniques. 8th ed. Elsevier, Beijing 2019: 337–394.
- Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis Res. 2021; 18(6): 14791641211058856.
- Vargel İ, Tuncel A, Baysal N, et al. Autologous adipose-derived tissue stromal vascular fraction (AD-tSVF) for knee osteoarthritis. Int J Mol Sci. 2022; 23(21).
- Xue R, Xiao H, Kumar V, et al. The molecular mechanism of renal tubulointerstitial inflammation promoting diabetic nephropathy. Int J Nephrol Renovasc Dis. 2023; 16: 241–252.
- Yan P, Yang Y, Zhang X, et al. Association of systemic immune-inflammation index with diabetic kidney disease in patients with type 2 diabetes: a cross-sectional study in Chinese population. Front Endocrinol (Lausanne). 2023; 14: 1307692.
- Yang J, Wang X, Zeng X, et al. One-step stromal vascular fraction therapy in osteoarthritis with tropoelastin-enhanced autologous stromal vascular fraction gel. Front Bioeng Biotechnol. 2024; 12: 1359212.
- Yaşar M, Çakmak H, Dündar S, et al. The role of microRNAs in corneal neovascularization and its relation to VEGF. Cutan Ocul Toxicol. 2020; 39(4): 341–347.
- Zanchi A, Jehle AW, Lamine F, et al. Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology. Swiss Med Wkly. 2023; 153: 40004.
- Zhang L, Chu W, Zheng L, et al. Zinc oxide nanoparticles from Cyperus rotundus attenuates diabetic retinopathy by inhibiting NLRP3 inflammasome activation in STZ-induced diabetic rats. J Biochem Mol Toxicol. 2020; 34(12): e22583.
- Zhao X, Guo J, Zhang F, et al. Therapeutic application of adipose-derived stromal vascular fraction in diabetic foot. Stem Cell Res Ther. 2020; 11(1): 394.
- Zohny MH, Cavalu S, Youssef ME, et al. Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: a novel approach for filling an unmet medical need. Biomed Pharmacother. 2022; 148: 112723.
